Adaptive Biotechnologies Corp (NAS:ADPT)
$ 6.109 -0.271 (-4.25%) Market Cap: 941.56 Mil Enterprise Value: 838.75 Mil PE Ratio: 0 PB Ratio: 4.20 GF Score: 81/100

Q4 2022 Adaptive Biotechnologies Corp Earnings Call Transcript

Feb 14, 2023 / 09:30PM GMT
Release Date Price: $8.68 (-0.12%)
Operator

Good day and thank you for standing by, and welcome to the Fourth Quarter and Full Year 2022 Conference Call. (Operator Instructions) I would now like to hand the conference over to your speaker today, Karina Calzadilla. You may go ahead.

Karina Calzadilla
Adaptive Biotechnologies Corporation - VP of IR

Thank you, Justin, and good afternoon, everyone. I would like to welcome you to Adaptive Biotechnologies fourth quarter and full year 2022 earnings conference call. Earlier today, we issued a press release reporting Adaptive financial results for the fourth quarter and full year of '22. The press release is available at www.Adaptivebiotech.com. We are conducting a live webcast of this call and we'll be referencing to a slide presentation that has been posted to the investor section in our corporate website.

During the call, management will make projections and other forward-looking statements within the meaning of federal securities laws regarding future events and the future

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot